Related Experiment Video

Updated: Aug 15, 2026

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
06:57

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections

Published on: May 8, 2017

Non cystic fibrosis bronchiectasis

E Dagli1

  • 1Department of Paediatric Pulmonology, Marmara University, Altunizade, Istanbul 81190, Turkey. edagli@superonline.com

Paediatric Respiratory Reviews
|November 3, 2005
PubMed

Insights

Childhood bronchiectasis, though decreasing, remains a significant challenge in developing nations. Further research is needed to understand its causes and optimize treatment strategies for affected children.

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases
  • Genetics

Background:

  • Bronchiectasis incidence is declining due to improved acute lower respiratory tract infection management and vaccination programs reducing pertussis and measles.
  • Despite declining rates, bronchiectasis persists as a critical issue in developing regions, often resulting from conditions like cystic fibrosis, immunodeficiency, and ciliary dyskinesia.
  • It represents a final common pathway for various lower respiratory tract insults in children.

Purpose of the Study:

  • To review the current understanding of childhood bronchiectasis, including its changing epidemiology.
  • To highlight the persistent challenges in diagnosis and management, particularly in resource-limited settings.
  • To identify key areas requiring further research, focusing on etiology and treatment optimization.

Main Methods:

  • Literature review of epidemiological trends and etiological factors.
  • Analysis of current medical and surgical treatment approaches for pediatric bronchiectasis.
  • Identification of knowledge gaps and research priorities.

Main Results:

  • Bronchiectasis is less common globally but remains a significant pediatric respiratory problem in developing countries.
  • Common underlying causes include cystic fibrosis, immunodeficiency, and ciliary dyskinesia.
  • Medical management is primary, but surgery is indicated for localized, severe, or treatment-refractory cases.

Conclusions:

  • Childhood bronchiectasis, while decreasing, continues to pose challenges, especially in developing regions.
  • Unanswered questions regarding etiology and optimal treatment necessitate further investigation.
  • Research is crucial to improve outcomes for children with this condition.

More Related Videos

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression08:58

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression

Published on: April 18, 2025

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.